Finally, the authors were able to reverse some of this pathology with pharmaceutical MEK inhibition but not PIK3 inhibition, supporting further investigation in the clinic of MEK inhibition in vascular malformation studies. This evidence concerns the gene MAP2K7 and vascular malformation.